Climb Bio, Inc. CLYM Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -30.9%+1.2pp | -32.1%-6.5pp | -25.6%-2.7pp | -22.9%+39.1pp | -62%-15.8pp | |
| Return on invested capital | -39.4%+14.8pp | -54.2%-1.2pp | -53%— | —— | -122.6%-5.5pp | |
| Liquidity | ||||||
| Current ratio | 27.9×+12.7× | 15.2×-3.2× | 18.4×+4.3× | 14.1×-0.2× | 14.3×-17.2× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $2.17-8.3% | $2.37-9.1% | $2.60-5.3% | $2.75-4.1% | $2.87-34.8% | |
| Valuation | ||||||
| Market capitalization | $724.95M+787% | $190.98M+40.2% | $136.21M+56.2% | $87.17M+5.9% | $82.32M-32.0% | |
| Price / book | 4.9×+4.5× | 1.2×+0.4× | 0.8×+0.3× | 0.5×0.0× | 0.4×-0.1× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Climb Bio, Inc.'s ratios come from?
- Every ratio is computed from Climb Bio, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.